Reference is made to the private placement (the “Private Placement”) completed in IDEX Biometrics ASA (the “Company”) on 17 September 2024, and to the subsequent offering completed in the Company on 29 November 2024 (the “Subsequent Offering”). The subscribers in the Private Placement and the Subsequent Offering were allocated two warrants, Warrants A and Warrants B (collectively, the “Warrants”), respectively, issued by the Company for every two Offer Shares allocated to, and paid by, them in the Private Placement and the Subsequent Offering. As previously announced by the Company, the Company shall use reasonable efforts to seek to ensure that the Warrants are admitted to trading on Euronext Oslo Børs.
The Warrants will be admitted to trading on Euronext Oslo Børs on 12 December 2024.
The Warrants have already been allocated to the subscribers of the Private Placement and the Subsequent Offering and will be tradable. Warrants A will be tradable from 12 December 2024 until 7 March 2025. Warrants B will be tradable from 12 December 2024 until 7 April 2025.
Warrants A may only be exercised within the first 14 days following the Company's announcement of its Q4 2024 financial report (announcement expected on 27 February 2025, and the expected exercise period is between 28 February 2025 and 13 March 2025), and all Warrants A not exercised within such period will lapse without compensation to the holder. Warrants B may only be exercised from 31 March 2025 to 11 April 2025, and all Warrants B not exercised within such period will lapse without compensation to the holder.
Each Warrant will give the holder a right to subscribe for one new share in the Company at a subscription price of NOK 0.15. The Warrants are expected to have an economic value.
For more information relating to the Warrants, please refer to the Prospectus approved and published by the Company on 13 November 2024.
For further information contact:
Marianne Bøe, Head of Investor Relations
Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com
Tel: +47 6783 9119
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.
For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)
About this notice:
This notice was issued by Marianne Bøe, Head of Investor Relations, on 12 December 2024 at 07:30 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。